A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
08/27/2026 10:07 AM - Business
Taiwan shares open higher
08/27/2026 09:07 AM - Society
Taiwan issues sea warning for Typhoon Saudel
08/27/2026 08:50 AM - Society
Magnitude 5.2 earthquake shakes southeastern Taiwan
08/27/2026 08:03 AM - Society
Chiayi sesame oil maker ordered to suspend operations over carcinogen
08/26/2026 08:40 PM